RKTO
Hoth Therapeutics, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$0.69
+0.51%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-54.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| May 28, 2026 | Linsley Wayne · director | A-Award | 75,000 | $0.71 |
| May 28, 2026 | Knie Robb · director, officer: CEO and President | A-Award | 550,000 | $0.71 |
| May 28, 2026 | Sarnoff David · director | A-Award | 75,000 | $0.71 |
| May 28, 2026 | Camarra Christopher Michael · director | A-Award | 75,000 | $0.71 |
| May 28, 2026 | Pavell Jeff · director | A-Award | 75,000 | $0.71 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing May 28, 2026